The innovative evolution of cancer gene and cellular therapies

被引：12

作者：

Lam, P. ^{[1
]}

Khan, G. ^{[2
]}

Stripecke, R. ^{[3
]}

Hui, K. M. ^{[1
,4
,5
]}

Kasahara, N. ^{[6
]}

Peng, K-W ^{[7
]}

Guinn, B-A ^{[2
,8
,9
]}

机构：

[1] Natl Canc Ctr, Div Cellular & Mol Res, Singapore, Singapore

[2] Univ Bedfordshire, Dept Life Sci, Luton LU1 3JU, Beds, England

[3] Hannover Med Sch, Lymphat Cell Therapy Program, Excellence Cluster Regenerat Biol REBIRTH, Hannover, Germany

[4] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore

[5] Duke NUS Grad Med Sch, Program Canc & Stem Cell Biol, Singapore, Singapore

[6] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA

[7] Mayo Clin, Dept Mol Med, Rochester, MN USA

[8] Univ Southampton, Canc Sci Unit, Southampton Univ Hosp, Southampton, Hants, England

[9] Kings Coll London, Dept Haematol Med, Sch Med, London WC2R 2LS, England

来源：

CANCER GENE THERAPY | 2013年 / 20卷 / 03期

关键词：

stem cells; immunotherapy; cancer research; TARGETED ONCOLYTIC POXVIRUS; T-CELLS; CARCINOEMBRYONIC ANTIGEN; CARCINOMA; LYMPHOCYTES; RECURRENCE; ACTIVATION; VECTORS; DIFFERENTIATION; 5-FLUOROURACIL;

D O I：

10.1038/cgt.2012.93

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

We provide an overview of the latest developments in cancer gene therapy-from the bench to early-stage clinical trials. We describe the most recent work of worldwide teams including experienced scientists and clinicians, reflecting the recent emergence of gene therapy from the 'Valley of Death'. The treatment efficacy of clinical gene therapy has now been shown in a number of diseases including cancer and we are observing a renewed interest by big pharmaceutical and biotechnology companies most obviously demonstrated by Amgen's acquisition of Biovex for up to USD$1 billion. There is an opportunity to be cautiously hopeful regarding the future of gene therapy in the clinic and we review here some of the most recent progress in the field. Cancer Gene Therapy (2013) 20, 141-149; doi:10.1038/cgt.2012.93; published online 1 February 2013

引用

页码：141 / 149

页数：9

共 50 条

[1] The innovative evolution of cancer gene and cellular therapies
P Lam
G Khan
R Stripecke
K M Hui
N Kasahara
K-W Peng
B-A Guinn
Cancer Gene Therapy, 2013, 20 : 141 - 149
[2] The Journal of Cancer Gene and Cellular Therapies
Sobol, R. E.
Scanlon, K. J.
CANCER GENE THERAPY, 2011, 18 (01) : 1 - 1
[3] The Journal of Cancer Gene and Cellular Therapies
R E Sobol
K J Scanlon
Cancer Gene Therapy, 2011, 18 : 1 - 1
[4] (R)Evolution with innovative Combination Therapies
Junker, Annette
ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 (12) : 708 - 708
[5] Application of innovative techniques in genetic and cellular therapies
Endo, Yori
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2023, 11
[6] CELLULAR THERAPIES IN CANCER
FRIDMAN, WH
MATHIOT, C
TARTOUR, E
DORVAL, T
THIOUNN, N
POUILLART, P
DEBRE, B
BULLETIN DU CANCER, 1995, 82 (03) : 235 - 236
[7] Innovative approaches for cancer therapies
Flanagan, A
GENETIC ENGINEERING NEWS, 2002, 22 (16): : 9 - +
[8] Cellular, gene therapies and Cytokines
Uhlin, M.
Gertow, J.
Okas, M.
Mattsson, J.
BONE MARROW TRANSPLANTATION, 2011, 46 : S310 - S310
[9] Gene and Cellular Therapies for Leukodystrophies
Aerts-Kaya, Fatima
van Til, Niek P.
PHARMACEUTICS, 2023, 15 (11)
[10] Evolution of the Innovative Therapies for Children With Cancer Consortium Trial Portfolio for Drug Development for Children With Cancer
Bautista, Francisco
Verdu-Amoros, Jaime
Geoerger, Birgit
Rubio-San-Simon, Alba
Paoletti, Xavier
Zwaan, C. Michel
Casanova, Michela
Marshall, Lynley V.
Carceller, Fernando
Doz, Francois
Lecinse, Carole
Vassal, Gilles
Pearson, Andrew D. J.
Kearns, Pamela
Moreno, Lucas
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (21) : 2516 - 2526

← 1 2 3 4 5 →